1.Nonoperative treatment of Legg-Calve-Perthes disease.
Kwang Jin RHEE ; Chan Hee PARK ; Jun Soung YANG ; Jin Sun JEONG
The Journal of the Korean Orthopaedic Association 1993;28(7):2522-2531
No abstract available.
Legg-Calve-Perthes Disease*
2.A Clinical Analysis of Ectopic Pregnancy.
Kyll Pal YOON ; Ywoung Koon YANG ; Woo Yeoul YANG ; Man Suk KO ; Ho Jun CHOI ; Soung Kwen SHIN
Korean Journal of Obstetrics and Gynecology 1997;40(4):793-800
The study was undertaken for the clinical evaluation and statistical analysis on the 222 patients with ectopic pregnancy who had been adbitted and treated at the Mokpo St.Columban's Hospital from Jan. 1, 1993 to Dec. 31, 1995. The results were obtained as follows. 1. Hospital incidence of ectopic pregnancy wasd 1 in 45 deliveries(222/10,078). 2. Ectopic pregnancy was found to occur most frequently in the age group, ranging from 31 to 35 years(36.9%). 3. Nullipara was 26.5% and woman who had experienced artificial abortion was 69.8%. 4. Hemoglobin value over 10.0 gm/dL was in 78.8% and below 8.9 gm/dL in 4.1%. 5. Initial systolic blood pressure rise above 100 mmHg was in 75.0%, the mean value was 104.5mmHg. 6. The clinical manifestations were appeared in 64.4% from the last menstrual peroid to the next 5~8 weeks. 7. Total amount of intraperitoneal hemorrhage between 100~1,000 ml was in 62.1%, above the 1,000 ml was in 29.3% and less than 100 ml was in 8.6%. 8. Ectopic pregnancy was implanted follopain tuve in 95.0% ovary in 4.5% and cervix in 0.5%. Among tubal pregnancies, ampulla portion was involved in 76.6%, interstitial portion in 3.1%, isthmic portion in 12.2% and fimbrial portion in 3.1%. 9. In the past history, the laparoscopic tubal ligation was in 18%, peritonitis was in 1.8%, appendectomy was in 7.2% and cesarean section was in 8.6%. 10. Culdocentesis was positive in 70.0% and urinary HCG test was positive in 90%. 11. 77.8% of total cases was treated by salpingectomy, 14.9% by salpingoophorectomy and 1.4% by hysterectomy. 12. Of 222 total cases, no death occurred.
Appendectomy
;
Blood Pressure
;
Cervix Uteri
;
Cesarean Section
;
Female
;
Hemorrhage
;
Humans
;
Hysterectomy
;
Incidence
;
Jeollanam-do
;
Ovary
;
Peritonitis
;
Pregnancy
;
Pregnancy, Ectopic*
;
Pregnancy, Tubal
;
Salpingectomy
;
Sterilization, Tubal
3.A Clinical Analysis of Ectopic Pregnancy.
Kyll Pal YOON ; Ywoung Koon YANG ; Woo Yeoul YANG ; Man Suk KO ; Ho Jun CHOI ; Soung Kwen SHIN
Korean Journal of Obstetrics and Gynecology 1997;40(4):793-800
The study was undertaken for the clinical evaluation and statistical analysis on the 222 patients with ectopic pregnancy who had been adbitted and treated at the Mokpo St.Columban's Hospital from Jan. 1, 1993 to Dec. 31, 1995. The results were obtained as follows. 1. Hospital incidence of ectopic pregnancy wasd 1 in 45 deliveries(222/10,078). 2. Ectopic pregnancy was found to occur most frequently in the age group, ranging from 31 to 35 years(36.9%). 3. Nullipara was 26.5% and woman who had experienced artificial abortion was 69.8%. 4. Hemoglobin value over 10.0 gm/dL was in 78.8% and below 8.9 gm/dL in 4.1%. 5. Initial systolic blood pressure rise above 100 mmHg was in 75.0%, the mean value was 104.5mmHg. 6. The clinical manifestations were appeared in 64.4% from the last menstrual peroid to the next 5~8 weeks. 7. Total amount of intraperitoneal hemorrhage between 100~1,000 ml was in 62.1%, above the 1,000 ml was in 29.3% and less than 100 ml was in 8.6%. 8. Ectopic pregnancy was implanted follopain tuve in 95.0% ovary in 4.5% and cervix in 0.5%. Among tubal pregnancies, ampulla portion was involved in 76.6%, interstitial portion in 3.1%, isthmic portion in 12.2% and fimbrial portion in 3.1%. 9. In the past history, the laparoscopic tubal ligation was in 18%, peritonitis was in 1.8%, appendectomy was in 7.2% and cesarean section was in 8.6%. 10. Culdocentesis was positive in 70.0% and urinary HCG test was positive in 90%. 11. 77.8% of total cases was treated by salpingectomy, 14.9% by salpingoophorectomy and 1.4% by hysterectomy. 12. Of 222 total cases, no death occurred.
Appendectomy
;
Blood Pressure
;
Cervix Uteri
;
Cesarean Section
;
Female
;
Hemorrhage
;
Humans
;
Hysterectomy
;
Incidence
;
Jeollanam-do
;
Ovary
;
Peritonitis
;
Pregnancy
;
Pregnancy, Ectopic*
;
Pregnancy, Tubal
;
Salpingectomy
;
Sterilization, Tubal
4.Violence in Korean medical dramas.
Kyoung Nam LEE ; Yang Weon KIM ; Deuk Hyun PARK ; Jun Cheol CHOI ; Woo Soung SHIN ; Yoo Sang YOON
Journal of the Korean Society of Emergency Medicine 2013;24(1):109-115
PURPOSE: Although violence occurs frequently in Korean television dramas, its description or definition is unusual. Many studies have shown that TV dramas have a powerful effect on society and the violence shown in medical dramas helps in comprehension of hospital violence occurring in real life. Therefore, this study will cover the types and levels of violence. METHODS: We selected five recent Korean medical dramas. These five dramas, which consisted of 94 episodes and were broadcast from 2007 to 2011, are analyzed. Violence is limited to the occurrence inside the hospital; violence that occurs outside of the hospital is excluded. Media violence is analyzed within PAT (perpetrator-action-target). In addition, the violence levels and violence relationships are analyzed. RESULTS: Among the types of violence, 88.5% is verbal abuse, 3.5% is physical threat, and 8.0% is physical violence. In comparison of the violence relationship, violence between a doctor and a doctor forms the highest rate of 72.6%. In the level of violence, 0 level of violence caused by verbal abuse is the highest (88.5%); however, 5 level of violence level, which is death, is not observed. There are 1475 minutes of violence scenes from 6243 minutes, which is 23.6% of total time. CONCLUSION: Frequency of violence in Korean medical dramas is higher than that of normal dramas. Considering the powerful influence of the mass media, the violence of medical dramas should be controlled. To resolve the problem, the role of advisory doctors seems important.
Comprehension
;
Drama
;
Korea
;
Mass Media
;
Television
;
Violence
5.The Use of Vapocoolant Spray for the Treatment of Minor Trauma in the Hospital Emergency Department.
Woo Soung SHIN ; Yang Weon KIM ; Yoo Sang YOON ; Ji Hoon CHA ; Jun Cheol CHOI ; Deuk Hyun PARK
Journal of the Korean Society of Emergency Medicine 2012;23(1):33-40
PURPOSE: Vapocoolant spray is used as an agent to relieve localized pain due to sport injury or intravenous cannulation. The aim of this study was to determine the effectiveness of vapocoolant spray in the treatment of minor trauma in a hospital emergency department. METHODS: We carried out a prospective randomized controlled trial of alert patients with minor trauma who visited our emergency department. The total of 90 participants, all over 14 years old, were divided into 3 groups: a 'NSAIDs IM' group (n=30), 'Vapocoolant spray' group (n=30), and 'NSAIDs IM with Vapocoolant spray' group (n=30). Patients rated their pain and satisfaction of treatment using a 100-mm visual analogue scale (VAS). We assessed pain by VAS 4 times: first upon arrival, and then at 15, 30 and 60 minutes after treatment. We also assessed their treatment satisfaction utilizing VAS at the point of discharge. In addition, we calculated the time between subject arrival and initial treatment. RESULTS: Groups did not differ significantly in terms of age or sex distribution. The mean of the VAS score did not differ significantly among the groups upon their arrival (p=0.885) and were observed as follows: 'NSAIDs IM' group 44.80+/-12.70 mm, 'Vapocoolant spray' group 45.20+/-10.49 mm, and 'NSAIDs IM with Vapocoolant spray' group 46.17+/-9.54 mm. At 15, 30 and 60 min after treatment, the mean reduction in VAS score significantly differed between groups (p<0.05). At 15 min after treatment the results were as follows: 'NSAIDs IM' group 5.27+/-3.26 mm, 'Vapocoolant spray' group 15.17+/-7.17 mm, and 'NSAIDs IM with Vapocoolant spray'group 14.57+/-4.07 mm. At 30 min after treatment the results were: 'NSAIDs IM' group 13.57+/-7.86 mm, 'Vapocoolant spray' group 19.47+/-9.96 mm, and 'NSAIDs IM with Vapocoolant spray' group 21.20+/-6.52 mm. At 60 min after treatment the results were: 'NSAIDs IM' group 25.73+/-8.07 mm, 'Vapocoolant spray' group 20.90+/-9.88 mm, and 'NSAIDs IM with Vapocoolant spray' group 28.93+/-6.66 mm. Satisfaction of treatment and initial treatment time differed between groups (p<0.05). For satisfaction of treatment, the median of VAS significantly differed between the 'NSAIDs IM' group and the 'NSAIDs IM with Vapocoolant spray' group [46.50(41-52) mm vs. 57.00(51-62) mm, p<0.0167]. Initial treatment time significantly differed between the 'NSAIDs IM' group and the other groups [22.50(13-34) min vs. 10.00(7-20) min and 13.00(7-20) min, p<0.0167]. CONCLUSION: Vapocoolant spray is effective in reducing pain with minor trauma in the hospital emergency department. We can simultaneously improve the patient treatment satisfaction and reduce initial treatment time by using the vapocoolant spray.
Catheterization
;
Emergencies
;
Humans
;
Pain Management
;
Prospective Studies
;
Sex Distribution
;
Sports
6.The Use of Vapocoolant Spray for the Treatment of Minor Trauma in the Hospital Emergency Department.
Woo Soung SHIN ; Yang Weon KIM ; Yoo Sang YOON ; Ji Hoon CHA ; Jun Cheol CHOI ; Deuk Hyun PARK
Journal of the Korean Society of Emergency Medicine 2012;23(1):33-40
PURPOSE: Vapocoolant spray is used as an agent to relieve localized pain due to sport injury or intravenous cannulation. The aim of this study was to determine the effectiveness of vapocoolant spray in the treatment of minor trauma in a hospital emergency department. METHODS: We carried out a prospective randomized controlled trial of alert patients with minor trauma who visited our emergency department. The total of 90 participants, all over 14 years old, were divided into 3 groups: a 'NSAIDs IM' group (n=30), 'Vapocoolant spray' group (n=30), and 'NSAIDs IM with Vapocoolant spray' group (n=30). Patients rated their pain and satisfaction of treatment using a 100-mm visual analogue scale (VAS). We assessed pain by VAS 4 times: first upon arrival, and then at 15, 30 and 60 minutes after treatment. We also assessed their treatment satisfaction utilizing VAS at the point of discharge. In addition, we calculated the time between subject arrival and initial treatment. RESULTS: Groups did not differ significantly in terms of age or sex distribution. The mean of the VAS score did not differ significantly among the groups upon their arrival (p=0.885) and were observed as follows: 'NSAIDs IM' group 44.80+/-12.70 mm, 'Vapocoolant spray' group 45.20+/-10.49 mm, and 'NSAIDs IM with Vapocoolant spray' group 46.17+/-9.54 mm. At 15, 30 and 60 min after treatment, the mean reduction in VAS score significantly differed between groups (p<0.05). At 15 min after treatment the results were as follows: 'NSAIDs IM' group 5.27+/-3.26 mm, 'Vapocoolant spray' group 15.17+/-7.17 mm, and 'NSAIDs IM with Vapocoolant spray'group 14.57+/-4.07 mm. At 30 min after treatment the results were: 'NSAIDs IM' group 13.57+/-7.86 mm, 'Vapocoolant spray' group 19.47+/-9.96 mm, and 'NSAIDs IM with Vapocoolant spray' group 21.20+/-6.52 mm. At 60 min after treatment the results were: 'NSAIDs IM' group 25.73+/-8.07 mm, 'Vapocoolant spray' group 20.90+/-9.88 mm, and 'NSAIDs IM with Vapocoolant spray' group 28.93+/-6.66 mm. Satisfaction of treatment and initial treatment time differed between groups (p<0.05). For satisfaction of treatment, the median of VAS significantly differed between the 'NSAIDs IM' group and the 'NSAIDs IM with Vapocoolant spray' group [46.50(41-52) mm vs. 57.00(51-62) mm, p<0.0167]. Initial treatment time significantly differed between the 'NSAIDs IM' group and the other groups [22.50(13-34) min vs. 10.00(7-20) min and 13.00(7-20) min, p<0.0167]. CONCLUSION: Vapocoolant spray is effective in reducing pain with minor trauma in the hospital emergency department. We can simultaneously improve the patient treatment satisfaction and reduce initial treatment time by using the vapocoolant spray.
Catheterization
;
Emergencies
;
Humans
;
Pain Management
;
Prospective Studies
;
Sex Distribution
;
Sports
7.Recurred Myofibroblastoma of Breast After Excision: A Case Report.
Yoon Ki CHA ; Ji Young KIM ; Myeong Ja JEONG ; Jae Hyung KIM ; Soung Hee KIM ; Soo Hyun KIM ; Woo Sun JUN ; Kyeong Mee PARK ; Keun Ho YANG
Journal of the Korean Society of Medical Ultrasound 2010;29(1):31-34
Myofibroblastoma of the breast is a rare benign mesenchymal tumor that is known to occur in middle-aged and elderly men, yet there are some recent reports showing no certain difference for the gender distribution of this malady. Localized mass excision can usually provide a complete cure. To the best of our knowledge, there have been no reports of metastasis or recurrence of this tumor. Here we describe the sonographic findings of a case of recurrent myofibroblastoma after surgical excision for suspected fibroadenomas in both breasts of a 25-year-old woman.
Adult
;
Aged
;
Breast
;
Female
;
Fibroadenoma
;
Humans
;
Male
;
Neoplasm Metastasis
;
Neoplasms, Muscle Tissue
;
Recurrence
8.Sciatic nerve regeneration using calcium phosphate coated conduit and brain-derived neurotrophic factor gene-transfected schwann cell in rat.
Won Jae CHOI ; Kang Min AHN ; Soon Jeong HWANG ; Pill Hoon CHOUNG ; Myung Jin KIM ; Nam Yeol KIM ; Sang Bae YOO ; Jeong Won JAHNG ; Hyun Man KIM ; Joong Soo KIM ; Yun Hee KIM ; Soung Min KIM ; Seung Jae OH ; Sung Jun KIM ; Byoung Eun YANG ; Jong Ho LEE
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2005;31(3):199-218
PURPOSE OF STUDY: Peripheral nerve regeneration depends on neurotrophism of distal nerve stump, recovery potential of neuron, supporting cell like Schwann cell and neurotrophic factors such as BDNF. Peripheral nerve regeneration can be enhanced by the conduit which connects the both sides of transected nerve. The conduit maintains the effects of neurotrophism and BDNF produced by Schwann cells which can be made by gene therapy. In this study, we tried to enhance the peripheral nerve regeneration by using calcium phosphate coated porous conduit and BDNF-Adenovirus infected Schwann cells in sciatic nerve of rats. MATERIALS AND METHODS: Microporous filter which permits the tissue fluid essential for nerve regeneration and does not permit infiltration of fibroblasts, was made into 2mm diameter and 17mm length conduit. Then it was coated with calcium phosphate to improve the Schwann cell adhesion and survival. The coated filter was evaluated by SEM examination and MTT assay. For effective allogenic Schwann cell culture, dorsal root ganglia of 1-day old rat were extracted and treated with enzyme and antimitotic Ara-C. Human BDNF cDNA was obtained from cDNA library and amplified using PCR. BDNF gene was inserted into adenovirus shuttle vector pAACCMVpARS in which E1 was deleted. We infected the BDNF-Ad into 293 human mammary kidney cell-line and obtained the virus plaque 2 days later. RT-PCR was performed to evaluate the secretion of BDNF in infected Schwann cells. To determine the most optimal m.o.i of BDNF-Ad, we infected the Schwann cells with LacZ adenovirus in 1, 20, 50, 75, 100, 250 m.o.i for 2 hours and stained with beta-galactosidase. Rats(n=24) weighing around 300g were used. Total 14mm sciatic nerve defect was made and connected with calcium phosphate coated conduits. Schwann cells(1x10(6)) or BDNF-Ad infected Schwann cells(1x10(6)) were injected in conduit and only media(MEM) was injected in control group. Twelve weeks after surgery, degree of nerve regeneration was evaluated with gait analysis, electrophysiologic measurements and histomorphometric analysis. RESULTS: 1. Microporous Millipore filter was effective conduit which permitted the adhesion of Schwann cells and inhibited the adhesion of fibroblast. We could enhance the Schwann cell adhesion and survival by coating Millipore filter with calcium phosphate. 2. Schwann cell culture technique using repeated treatment of Ara-C and GDNF was established. The mean number of Schwann cells obtained 1 and 2 weeks after the culture were 1.54+/-4.0*10(6) and 9.66+/-9.6*10(6). 3. The mRNA of BDNF in BDNF-Ad infected Schwann cells was detected using RT-PCR. In Schwann cell 0.69 microgram/microliter of DNA was detected and in BDNF-Adenovirus transfected Schwann cell 0.795 microgram/microliter of DNA was detected. The most effective infection concentration was determined by LacZ Adenovirus and 75 m.o.i was found the most optimal. CONCLUSION: BDNF-Ad transfected Schwann cells successfully regenerated the 14mm nerve gap which was connected with calcium phosphate coated Millipore filter. The BDNF-Ad group showed better results compared with Schwann cells only group and control group in aspect to sciatic function index, electrophysiologic measurements and histomorphometric analysis.
Adenoviridae
;
Animals
;
beta-Galactosidase
;
Brain-Derived Neurotrophic Factor*
;
Calcium*
;
Cell Adhesion
;
Cell Culture Techniques
;
Cytarabine
;
DNA
;
DNA, Complementary
;
Fibroblasts
;
Gait
;
Ganglia, Spinal
;
Gene Library
;
Genetic Therapy
;
Genetic Vectors
;
Glial Cell Line-Derived Neurotrophic Factor
;
Humans
;
Kidney
;
Micropore Filters
;
Nerve Growth Factors
;
Nerve Regeneration
;
Neurons
;
Peripheral Nerves
;
Polymerase Chain Reaction
;
Rats*
;
Regeneration*
;
RNA, Messenger
;
Schwann Cells
;
Sciatic Nerve*
9.Evaluation of clinical course in patients with eosinophilic bronchitis: A prospective follow up study.
Jong Kun PARK ; Sung Woo PARK ; Jae Hak LEE ; Jong Sook PARK ; Ki Hyun SEO ; Young Mok LEE ; Jun Hyuk LEE ; An Soo JANG ; Jai Soung PARK ; Yang Ki KIM ; Sang Joon PARK ; Soo Taek UH ; Yong Hoon KIM ; Choon Sik PARK
Journal of Asthma, Allergy and Clinical Immunology 2003;23(4):740-748
BACKGROUND: Eosinophilic bronchitis (EB) presents as a chronic cough and sputum eosinophilia without airflow limitation and bronchial hyperreactivity. The long-term clinical courses remain unknown. OBJECTIVE AND METHOD: The aim of this study was to evaluate how frequently EB recurs and whether it develops into chronic airway obstruction. Cough severity, FEV1, PC20 methacholine and sputum eosinophil percentages were serially measured in 36 subjects for up to 48 months. RESULT: Five subjects developed recurrent episodes of EB (RG) between 4 to 6 months after the first episode of EB. Asthma developed in the 9th month of the study in one of these subjects and a progressive FEV1 reduction exceeding 20% was observed in two. Nineteen subjects had no recurrence of EB (NRG). However, sputum eosinophilia recurred between 4 and 24 months in 10 subjects of the NRG, though this was without cough or FEV1 reduction. The follow-up eosinophil percentages were significantly higher in the RG than NRG group with recurrent sputum eosinophilia. CONCLUSION: About 14% of EB cases experience repeated episodes of EB and in about 30%, the EB recurs as asymptomatic sputum eosinophilia. Moreover, the extent of sputum eosinophilia was found to be associated with the recurrence of eosinophilic bronchitis, which leads to an airflow rate deterioration. These results suggest that repeated episode of EB is a risk factor for the development of asthma or chronic airway obstruction.
Airway Obstruction
;
Asthma
;
Bronchial Hyperreactivity
;
Bronchitis*
;
Cough
;
Eosinophilia
;
Eosinophils*
;
Follow-Up Studies*
;
Humans
;
Methacholine Chloride
;
Prospective Studies*
;
Recurrence
;
Risk Factors
;
Sputum
10.Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
Jeong-Ju YOO ; Yang Jae YOO ; Woo Ram MOON ; Seung Up KIM ; Soung Won JEONG ; Ha Na PARK ; Min Gyu PARK ; Jae Young JANG ; Su Yeon PARK ; Beom Kyung KIM ; Jun Yong PARK ; Do Young KIM ; Sang Hoon AHN ; Kwang-Hyub HAN ; Sang Gyune KIM ; Young Seok KIM ; Ji Hoon KIM ; Jong Eun YEON ; Kwan Soo BYUN
The Korean Journal of Internal Medicine 2020;35(6):1346-1353
Background/Aims:
The controlled attenuation parameter (CAP), based on transient elastography, is widely used for noninvasive assessment of the degree of hepatic steatosis (HS). We investigated the correlation of the degree HS between CAP and ultrasound (US) in patients with HS.
Methods:
In total, 986 patients with US-based HS who underwent transient elastography within 1 month were evaluated. The US-based grade of HS was categorized as mild (grade 1), moderate (grade 2), or severe (grade 3).
Results:
The CAP was significantly correlated with the US-based grade of HS (r = 0.458, p < 0.001). The median CAP value of each US-based HS grade showed a positive correlation with grade (271.1, 303.7, and 326.7 dB/m for grades 1, 2, and 3). In a multivariate analysis, the US-based HS grade, body mass index, serum albumin, alanine aminotransferase, and total cholesterol, and liver stiffness were all significantly correlated with the CAP value (all p < 0.05). The areas under the receiver operating characteristic curves for grade 2 to 3 and grade 3 HS were 0.749 (95% confidence interval [CI], 0.714 to 0.784) and 0.738 (95% CI, 0.704 to 0.772). The optimal cut-off CAP values to maximize the sum of the sensitivity and specificity for grade 2 to 3 and grade 3 HS were 284.5 dB/m (sensitivity 78.6%, specificity 61.7%) and 298.5 dB/m (sensitivity 84.6%, specificity 55.6%).
Conclusions
The correlation of the degree of HS between CAP and US was significantly high in patients with HS, and the optimal cut-off CAP values for grade 2 to 3 and grade 3 HS were 284.5 and 298.5 dB/m.